2-178663311-A-C

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBP6

The NM_001267550.2(TTN):​c.36655T>G​(p.Leu12219Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 11/14 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.18 ( 2431 hom., cov: 23)
Exomes 𝑓: 0.11 ( 34361 hom. )
Failed GnomAD Quality Control

Consequence

TTN
NM_001267550.2 missense

Scores

10

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:4

Conservation

PhyloP100: -4.21

Publications

11 publications found
Variant links:
Genes affected
TTN (HGNC:12403): (titin) This gene encodes a large abundant protein of striated muscle. The product of this gene is divided into two regions, a N-terminal I-band and a C-terminal A-band. The I-band, which is the elastic part of the molecule, contains two regions of tandem immunoglobulin domains on either side of a PEVK region that is rich in proline, glutamate, valine and lysine. The A-band, which is thought to act as a protein-ruler, contains a mixture of immunoglobulin and fibronectin repeats, and possesses kinase activity. An N-terminal Z-disc region and a C-terminal M-line region bind to the Z-line and M-line of the sarcomere, respectively, so that a single titin molecule spans half the length of a sarcomere. Titin also contains binding sites for muscle associated proteins so it serves as an adhesion template for the assembly of contractile machinery in muscle cells. It has also been identified as a structural protein for chromosomes. Alternative splicing of this gene results in multiple transcript variants. Considerable variability exists in the I-band, the M-line and the Z-disc regions of titin. Variability in the I-band region contributes to the differences in elasticity of different titin isoforms and, therefore, to the differences in elasticity of different muscle types. Mutations in this gene are associated with familial hypertrophic cardiomyopathy 9, and autoantibodies to titin are produced in patients with the autoimmune disease scleroderma. [provided by RefSeq, Feb 2012]
TTN-AS1 (HGNC:44124): (TTN antisense RNA 1) This gene encodes a non-coding RNA transcribed from the opposite strand to the titin gene. [provided by RefSeq, Aug 2016]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0017544031).
BP6
Variant 2-178663311-A-C is Benign according to our data. Variant chr2-178663311-A-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 220982.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TTNNM_001267550.2 linkc.36655T>G p.Leu12219Val missense_variant Exon 173 of 363 ENST00000589042.5 NP_001254479.2 A0A0A0MTS7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TTNENST00000589042.5 linkc.36655T>G p.Leu12219Val missense_variant Exon 173 of 363 5 NM_001267550.2 ENSP00000467141.1 A0A0A0MTS7

Frequencies

GnomAD3 genomes
AF:
0.177
AC:
20356
AN:
115166
Hom.:
2428
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.210
Gnomad AMI
AF:
0.426
Gnomad AMR
AF:
0.222
Gnomad ASJ
AF:
0.184
Gnomad EAS
AF:
0.448
Gnomad SAS
AF:
0.309
Gnomad FIN
AF:
0.141
Gnomad MID
AF:
0.208
Gnomad NFE
AF:
0.130
Gnomad OTH
AF:
0.171
GnomAD2 exomes
AF:
0.0997
AC:
21960
AN:
220158
AF XY:
0.0944
show subpopulations
Gnomad AFR exome
AF:
0.137
Gnomad AMR exome
AF:
0.166
Gnomad ASJ exome
AF:
0.0592
Gnomad EAS exome
AF:
0.333
Gnomad FIN exome
AF:
0.0227
Gnomad NFE exome
AF:
0.0503
Gnomad OTH exome
AF:
0.118
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.105
AC:
137173
AN:
1302676
Hom.:
34361
Cov.:
34
AF XY:
0.111
AC XY:
71844
AN XY:
647128
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.177
AC:
5119
AN:
28992
American (AMR)
AF:
0.191
AC:
7039
AN:
36772
Ashkenazi Jewish (ASJ)
AF:
0.156
AC:
3679
AN:
23656
East Asian (EAS)
AF:
0.494
AC:
16952
AN:
34308
South Asian (SAS)
AF:
0.289
AC:
19912
AN:
68906
European-Finnish (FIN)
AF:
0.127
AC:
6257
AN:
49314
Middle Eastern (MID)
AF:
0.163
AC:
591
AN:
3636
European-Non Finnish (NFE)
AF:
0.0697
AC:
69884
AN:
1003242
Other (OTH)
AF:
0.144
AC:
7740
AN:
53850
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.273
Heterozygous variant carriers
0
5772
11544
17317
23089
28861
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
992
1984
2976
3968
4960
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.177
AC:
20375
AN:
115242
Hom.:
2431
Cov.:
23
AF XY:
0.176
AC XY:
9706
AN XY:
55072
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.210
AC:
6215
AN:
29608
American (AMR)
AF:
0.223
AC:
2363
AN:
10616
Ashkenazi Jewish (ASJ)
AF:
0.184
AC:
501
AN:
2724
East Asian (EAS)
AF:
0.448
AC:
1415
AN:
3162
South Asian (SAS)
AF:
0.308
AC:
910
AN:
2958
European-Finnish (FIN)
AF:
0.141
AC:
1162
AN:
8248
Middle Eastern (MID)
AF:
0.212
AC:
51
AN:
240
European-Non Finnish (NFE)
AF:
0.130
AC:
7233
AN:
55498
Other (OTH)
AF:
0.175
AC:
285
AN:
1624
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.293
Heterozygous variant carriers
0
1148
2296
3444
4592
5740
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
196
392
588
784
980
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.186
Hom.:
814
ExAC
AF:
0.0689
AC:
8020

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1Benign:1
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Variant has not been reported. Only affects this transcript. -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:2
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jun 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Autosomal recessive limb-girdle muscular dystrophy type 2J;C1858763:Dilated cardiomyopathy 1G Benign:1
Jan 20, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.36
T
BayesDel_noAF
Benign
-0.76
CADD
Benign
0.012
DANN
Benign
0.63
Eigen
Benign
-2.3
Eigen_PC
Benign
-2.3
FATHMM_MKL
Benign
0.0029
N
LIST_S2
Benign
0.068
T
MetaRNN
Benign
0.0018
T
MetaSVM
Benign
-0.98
T
PhyloP100
-4.2
Vest4
0.026
MPC
0.084
ClinPred
0.00046
T
GERP RS
-4.3
Mutation Taster
=94/6
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12994774; hg19: chr2-179528038; COSMIC: COSV59895468; COSMIC: COSV59895468; API